# Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study

> **NCT03512860** · PHASE1 · COMPLETED · sponsor: **Estetra** · enrollment: 24 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** E4/DRSP
- **DRUG:** VAL

## Key facts

- **NCT ID:** NCT03512860
- **Lead sponsor:** Estetra
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-12
- **Primary completion:** 2018-10-08
- **Final completion:** 2018-10-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03512860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03512860, "Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03512860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*